{"id":8218,"date":"2020-07-01T12:00:18","date_gmt":"2020-07-01T16:00:18","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/medication-caused-side-effects-lead-to-lawsuit\/"},"modified":"2022-08-18T21:16:09","modified_gmt":"2022-08-19T01:16:09","slug":"ilaca-bagli-yan-etkiler-davaya-yol-acti","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/ilaca-bagli-yan-etkiler-davaya-yol-acti\/","title":{"rendered":"Davaya Neden Olabilecek \u0130la\u00e7 Kaynakl\u0131 Yan Etkiler"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Re\u00e7etesiz sat\u0131lanlar da dahil olmak \u00fczere \u00e7o\u011fu ila\u00e7 istenmeyen ikincil yan etkilere neden olabilir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00d6rne\u011fin, so\u011fu\u011fu tedavi eden ama uykunuzu getiren bir so\u011fuk alg\u0131nl\u0131\u011f\u0131 ilac\u0131, kalbinizi h\u0131zland\u0131ran sin\u00fcs dekonjestanlar\u0131 ve kanama ve mide \u00fclseri gibi ciddi yan etkilere neden olabilen aspirini ele alal\u0131m.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">T\u00fcm bunlar\u0131n nedeni, insan v\u00fccudunun, sorunsuz \u00e7al\u0131\u015fmas\u0131 i\u00e7in kontrol edilmesi gereken kimyasallardan olu\u015fan \u00e7ok karma\u015f\u0131k bir yap\u0131 olmas\u0131d\u0131r. Kullanabilece\u011finiz baz\u0131 ila\u00e7lar, i\u015flevleri dengelemek ve belirli bir durumu tedavi etmek i\u00e7in v\u00fccudun d\u00fczenleyici kimyasallar\u0131ndan birini de\u011fi\u015ftirerek \u00e7al\u0131\u015f\u0131r; ancak ayn\u0131 zamanda v\u00fccudunuzdaki di\u011fer s\u00fcre\u00e7leri de etkileyebilir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bu yan etkilerin baz\u0131lar\u0131 \u00f6nemsizdir ve kendi kendine ge\u00e7ebilirken, di\u011ferlerinin sa\u011fl\u0131\u011f\u0131n\u0131z \u00fczerinde ciddi, uzun vadeli etkileri olabilir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Yan etkilerle u\u011fra\u015fmak, insanlar\u0131n ila\u00e7lar\u0131 kulland\u0131klar\u0131nda ald\u0131klar\u0131 bilin\u00e7li bir risktir, \u00e7\u00fcnk\u00fc genellikle devam eden sa\u011fl\u0131k yararlar\u0131, yan etkilerin verdi\u011fi rahats\u0131zl\u0131ktan daha fazlad\u0131r. Ancak etik ve yasal olarak hastalar olas\u0131 yan etkiler konusunda bilgilendirilmelidir; aksi takdirde, ilac\u0131n kendi durumlar\u0131n\u0131 tedavi etme yetene\u011finin di\u011fer olumsuz sonu\u00e7lara yol a\u00e7ma riskine de\u011fip de\u011fmeyece\u011fine karar verirken bilin\u00e7li bir karar veremezler.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u0130la\u00e7 \u00fcreticisi veya distrib\u00fct\u00f6r\u00fcn\u00fcn, bir ilac\u0131n olas\u0131 yan etkilerini hastalar\u0131na bildirmemesi ve \u00f6zellikle bu bilginin bilerek saklanmas\u0131 durumunda, olumsuz sonu\u00e7tan zarar g\u00f6ren ma\u011fdurlar, u\u011frad\u0131klar\u0131 zarar\u0131n tazmini i\u00e7in dava a\u00e7abilecektir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bir ilac\u0131n yan etkilerinin dava konusu olup olmamas\u0131 aras\u0131ndaki fark birka\u00e7 fakt\u00f6re ba\u011fl\u0131d\u0131r.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Bir \u0130lac\u0131n Yan Etkisinin Dava A\u00e7\u0131lmaya De\u011fer Olup Olmad\u0131\u011f\u0131n\u0131 Belirleyen Fakt\u00f6rler<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Her y\u0131l 1,5 milyondan fazla insan hastanelere kald\u0131r\u0131l\u0131yor <\/span><a href=\"https:\/\/health.usnews.com\/health-news\/patient-advice\/articles\/2016-09-27\/the-danger-in-taking-prescribed-medications\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">farmas\u00f6tik ila\u00e7lar\u0131n yan etkileri nedeniyle<\/span><\/a><span style=\"font-weight: 400;\">. Bu ma\u011fdurlardan biriyseniz, dava a\u00e7mak i\u00e7in, tehlikeli yan etkilerin, \u00fcreticinin halk\u0131 bilgilendirmedi\u011fi veya \u00fcreticinin bilgisi olmad\u0131\u011f\u0131 ilaca verilen olumsuz tepkiler oldu\u011funu kan\u0131tlaman\u0131z gerekir. Yetersiz uyu\u015fturucu testinden kaynaklanan etkiler.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">bir durumda yapmak i\u00e7in <\/span><a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">ila\u00e7 davas\u0131<\/span><\/a><span style=\"font-weight: 400;\">yaralanman\u0131z\u0131n a\u015fa\u011f\u0131dakilerden biri nedeniyle daval\u0131n\u0131n hatas\u0131 oldu\u011funu kan\u0131tlaman\u0131z gerekir:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">\u0130lac\u0131n kusurlu \u00fcretimi;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">\u0130lac\u0131n hatal\u0131 tasar\u0131m\u0131; veya<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Yan etkilere ili\u015fkin yeterli uyar\u0131lar\u0131n veya kullan\u0131m talimatlar\u0131n\u0131n verilmemesi.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Doktorlar ila\u00e7lar\u0131 tavsiye ettiklerinde, bunlar\u0131 bir hastaya re\u00e7ete etmeden \u00f6nce a\u015fa\u011f\u0131daki fakt\u00f6rleri de\u011ferlendirmek konusunda me\u015fru bir sorumlulu\u011fa sahiptirler:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">\u0130lac\u0131n ortak yan etkileri;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Re\u00e7etenin hastan\u0131n kulland\u0131\u011f\u0131 di\u011fer ila\u00e7larla ba\u011flant\u0131s\u0131; Ve<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Hastan\u0131n genel sa\u011fl\u0131\u011f\u0131 \u0131\u015f\u0131\u011f\u0131nda ilac\u0131n kar\u015f\u0131la\u015ft\u0131rmal\u0131 riskleri ve yararlar\u0131.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Eczac\u0131, re\u00e7ete edilen ila\u00e7lar\u0131 vermeli ve doktorun talimat\u0131n\u0131 do\u011fru bir \u015fekilde okumal\u0131 ve do\u011fru bir \u015fekilde re\u00e7ete edilen dozajla doldurmal\u0131d\u0131r. Doktorlar, re\u00e7ete ettikleri bir ila\u00e7 nedeniyle ba\u015f\u0131n\u0131za bir \u015fey gelirse de su\u00e7u payla\u015fabilirler: \u00f6rne\u011fin, bir doktor yanl\u0131\u015f doz re\u00e7ete etmi\u015f veya alerjilerinizi ve di\u011fer ila\u00e7lar\u0131n\u0131z\u0131 dikkate almam\u0131\u015fsa.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sa\u011fl\u0131k uzman\u0131n\u0131z\u0131n size ilac\u0131 re\u00e7ete etmede hatal\u0131 olmas\u0131 nedeniyle, ilac\u0131n kendisindeki bir hatadan de\u011fil, olumsuz, kal\u0131c\u0131 yan etkilerden \u015fikayet\u00e7iyseniz, bir \u015fikayette bulunabilirsiniz. <\/span><a href=\"\/tr\/uygulama-alanlari-2\/tibbi-uygulama-hatasi\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">t\u0131bbi uygulama hatas\u0131 davas\u0131<\/span><\/a><span style=\"font-weight: 400;\"> doktor veya sa\u011flay\u0131c\u0131dan \u00fccret almak.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Ar\u0131zal\u0131 \u0130la\u00e7lar\u0131n Yayg\u0131n Yan Etkileri<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">2016 y\u0131l\u0131nda re\u00e7eteli ila\u00e7lar <\/span><a href=\"https:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2017.1299\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">$328,6 milyar<\/span><\/a><span style=\"font-weight: 400;\"> Amerika Birle\u015fik Devletleri&#039;ndeki ulusal sa\u011fl\u0131kla ilgili harcamalar\u0131n oran\u0131.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">FDA yeni ila\u00e7lar\u0131 sat\u0131lmadan \u00f6nce onaylamal\u0131d\u0131r. Ancak ila\u00e7 ruhsatland\u0131rma \u00f6ncesinde, s\u0131ras\u0131nda veya sonras\u0131nda herhangi bir zamanda sorunlar ortaya \u00e7\u0131kabilir. Re\u00e7eteli ila\u00e7lar\u0131n neden olabilece\u011fi baz\u0131 ciddi t\u0131bbi yan etkiler \u015funlard\u0131r:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Fel\u00e7;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Akci\u011fer hastal\u0131\u011f\u0131;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">karaci\u011fer toksisitesi;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">B\u00f6brek hastal\u0131\u011f\u0131 veya b\u00f6brek yetmezli\u011fi;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Do\u011fu\u015ftan gelen engeller;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Kal\u0131c\u0131 sa\u00e7 d\u00f6k\u00fclmesi;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Doku nekrozu;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Mesane kanseri;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Kalp krizi veya kalp yetmezli\u011fi;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Kemik k\u0131r\u0131\u011f\u0131;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">G\u00f6rme kayb\u0131; Ve<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ani \u00f6l\u00fcm.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Devam Eden \u0130la\u00e7 Vakas\u0131: Elmiron<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Halihaz\u0131rda, baz\u0131lar\u0131 y\u0131llard\u0131r devam eden \u00e7e\u015fitli aktif uyu\u015fturucu davalar\u0131 bulunmaktad\u0131r. Aktif davalar, Accutane gibi akne ila\u00e7lar\u0131, Yaz, Yasmin ve Ocella gibi do\u011fum kontrol ila\u00e7lar\u0131 ve Zithromax gibi antibiyotiklerle ilgili davalar\u0131 i\u00e7erir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Son zamanlardaki ciddi bir vaka, <\/span><a href=\"\/tr\/article\/receteli-ilac-elmiron-olabilir-neden-gorme-kaybina\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">mesane ilac\u0131 Elmiron<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Yeni ara\u015ft\u0131rmalar, interstisyel sistit tedavisinde kullan\u0131lan Elmiron alman\u0131n hastay\u0131 g\u00f6z bozukluklar\u0131 ve g\u00f6rme kayb\u0131 geli\u015ftirme riskine soktu\u011funu g\u00f6stermektedir. \u0130lac\u0131n ciddi yan etkileri, retinan\u0131n merkezi g\u00f6r\u00fc\u015ften sorumlu bir par\u00e7as\u0131 olan makulaya zarar vererek potansiyel olarak kal\u0131c\u0131 k\u00f6rl\u00fc\u011fe neden olabilecek g\u00f6rme kayb\u0131na neden olabilir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hastalar bu riskler konusunda bilgilendirilmedi ve bu nedenle ilac\u0131 kullanmay\u0131 se\u00e7erken nitelikli bir karar veremediler.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u0130nterstisyel sistit, mesaneyi ve pelvisi etkileyen kronik bir durumdur. Bu durum genellikle kad\u0131nlar\u0131 etkiler ve belirtileri \u015funlard\u0131r;<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Kronik pelvik a\u011fr\u0131<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">idrar aciliyeti<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Mesane a\u011fr\u0131s\u0131 ve rahats\u0131zl\u0131\u011f\u0131<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Genellikle k\u00fc\u00e7\u00fck miktarlarda s\u0131k idrara \u00e7\u0131kma<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Yukar\u0131daki semptomlar i\u00e7in bir hastaneye gittiyseniz, muhtemelen size Elmiron verildi. Siz veya sevdi\u011finiz biri ilac\u0131 ald\u0131ysa ve bu olumsuz yan etkileri ya\u015f\u0131yorsa, yasal i\u015flem i\u00e7in gerek\u00e7eniz olabilir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">bu <\/span><a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/national-elmiron-eye-disease-lawyers\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Elmiron dava avukatlar\u0131<\/span><\/a><span style=\"font-weight: 400;\"> at Napoli Shkolnik  are currently fighting for patients who were not warned of these damaging effects.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hastalar, sa\u011fl\u0131klar\u0131 i\u00e7in m\u00fcmk\u00fcn olan en iyi kararlar\u0131 verebilmeleri i\u00e7in ila\u00e7lar\u0131n zararl\u0131 etkileri hakk\u0131nda yeterince bilgilendirilme hakk\u0131na sahiptir. Ancak hastalar bu temel bilgiyi reddetti. Elmiron&#039;un \u00fcreticisi Janssen Pharmaceuticals sorumlu tutulmal\u0131 ve bu ihmal nedeniyle hayatlar\u0131 etkilenen ve baz\u0131 durumlarda kal\u0131c\u0131 olarak de\u011fi\u015fen ki\u015filere tazminat \u00f6demelidir.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Re\u00e7etesiz sat\u0131lanlar da dahil olmak \u00fczere \u00e7o\u011fu ila\u00e7 istenmeyen ikincil yan etkilere neden olabilir. \u00d6rne\u011fin, so\u011fu\u011fu tedavi eden ama uykunuzu getiren bir so\u011fuk alg\u0131nl\u0131\u011f\u0131 ilac\u0131 al\u0131n, sin\u00fcs...<\/p>","protected":false},"author":3,"featured_media":8219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[],"class_list":["post-8218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8218"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8218\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8219"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}